RT Journal Article
SR Electronic
T1 Management of corticosteroid-induced osteoporosis
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 98
OP 101
DO 10.1136/dtb.2010.09.0047
VO 48
IS 9
YR 2010
UL http://dtb.bmj.com/content/48/9/98.abstract
AB Relevant BNF section: BNF 6.6 Treatment with corticosteroids can adversely affect bone metabolism. In particular, it lowers bone mineral density (BMD) and increases the likelihood of fragility fractures, the hallmarks of osteoporosis, hence the term ‘corticosteroid-induced osteoporosis’.1 Since corticosteroids are used for a wide variety of inflammatory conditions, corticosteroid-induced osteoporosis represents a substantial disease burden. Here we aim to provide advice on prophylaxis and treatment for osteoporosis in adults receiving corticosteroid therapy.